- Scientists studied why muscles get weaker with age.
- The study used older mice in tests.
- A protein system in cells changed in aging.
- This change made muscle cells work worse.
- A protein regulator increased bad protein production.
- The mice did long treadmill endurance runs.
- Some older mice stayed inactive as controls.
- After exercise, active mice had lower bad activity.
- Exercise reduced the harmful protein levels in muscle.
- Exercise can help protect muscles during aging.
Difficult words
- protein — a natural substance in cells and foods
- regulator — a thing that controls cell proteins
- endurance — ability to do long physical activity
- inactive — not moving or not doing physical activity
- control — a group used for comparison in a studycontrols
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you exercise?
- Do you think exercise can help older people stay strong?
- Have you ever used a treadmill?
Related articles
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Gut has a backup system for IgA antibodies
Researchers found two different routes that make IgA antibodies in the gut. Early IgA often comes from non‑germinal center cells but later from germinal centers; both types showed similar specificity and mutations, which may help vaccine design.
Which childhood food allergies are outgrown?
Many children outgrow milk and egg allergies, while peanut, tree nut, sesame and shellfish allergies often persist. Factors such as IgE levels, allergy severity and genetics affect whether a child becomes tolerant and which treatments help.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.